Terms: = Breast cancer AND FAT1, CDHF7, 2195, ME5, hFat1, CDHR8 AND Treatment
14 results:
1. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
[TBL] [Abstract] [Full Text] [Related]
2. Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategies.
Liu Q; Zhang J; Guo C; Wang M; Wang C; Yan Y; Sun L; Wang D; Zhang L; Yu H; Hou L; Wu C; Zhu Y; Jiang G; Zhu H; Zhou Y; Fang S; Zhang T; Hu L; Li J; Liu Y; Zhang H; Zhang B; Ding L; Robles AI; Rodriguez H; Gao D; Ji H; Zhou H; Zhang P
Cell; 2024 Jan; 187(1):184-203.e28. PubMed ID: 38181741
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.
Wang Y; Song X; Song Y; Fang K; Chang X
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17253-17268. PubMed ID: 37804426
[TBL] [Abstract] [Full Text] [Related]
4. Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage breast cancer.
Zhao F; Miyashita M; Hattori M; Yoshimatsu T; Howard F; Kaneva K; Jones R; Bell JSK; Fleming GF; Jaskowiak N; Nanda R; Zheng Y; Huo D; Olopade OI
JAMA Netw Open; 2023 Mar; 6(3):e233329. PubMed ID: 36995716
[TBL] [Abstract] [Full Text] [Related]
5. A Multicentre Retrospective Study of Fulvestrant Use and Efficacy in Advanced/Metastatic breast cancer.
Lerner A; Keshwani K; Okines A; Sanderson B; Board RE; Flynn M; Sharkey E; Konstantis A; Roylance R; Hanna D; King J; Murphy R; Rehman F; Guppy AE; Westbury C; Takeuchi E; Spurrell E; Jayaweera HK; Raja F
Clin Oncol (R Coll Radiol); 2022 Apr; 34(4):261-266. PubMed ID: 35027287
[TBL] [Abstract] [Full Text] [Related]
6. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive breast cancer.
Di Modica M; Gargari G; Regondi V; Bonizzi A; Arioli S; Belmonte B; De Cecco L; Fasano E; Bianchi F; Bertolotti A; Tripodo C; Villani L; Corsi F; Guglielmetti S; Balsari A; Triulzi T; Tagliabue E
Cancer Res; 2021 Apr; 81(8):2195-2206. PubMed ID: 33483370
[TBL] [Abstract] [Full Text] [Related]
7. Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma.
Huang C; Chen L; Savage SR; Eguez RV; Dou Y; Li Y; da Veiga Leprevost F; Jaehnig EJ; Lei JT; Wen B; Schnaubelt M; Krug K; Song X; Cieślik M; Chang HY; Wyczalkowski MA; Li K; Colaprico A; Li QK; Clark DJ; Hu Y; Cao L; Pan J; Wang Y; Cho KC; Shi Z; Liao Y; Jiang W; Anurag M; Ji J; Yoo S; Zhou DC; Liang WW; Wendl M; Vats P; Carr SA; Mani DR; Zhang Z; Qian J; Chen XS; Pico AR; Wang P; Chinnaiyan AM; Ketchum KA; Kinsinger CR; Robles AI; An E; Hiltke T; Mesri M; Thiagarajan M; Weaver AM; Sikora AG; Lubiński J; Wierzbicka M; Wiznerowicz M; Satpathy S; Gillette MA; Miles G; Ellis MJ; Omenn GS; Rodriguez H; Boja ES; Dhanasekaran SM; Ding L; Nesvizhskii AI; El-Naggar AK; Chan DW; Zhang H; Zhang B;
Cancer Cell; 2021 Mar; 39(3):361-379.e16. PubMed ID: 33417831
[TBL] [Abstract] [Full Text] [Related]
8. Sequencing Endocrine Therapy for Metastatic breast cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?
Xi J; Ma CX
Curr Oncol Rep; 2020 May; 22(6):57. PubMed ID: 32415339
[TBL] [Abstract] [Full Text] [Related]
9. Identifying Circulating Tumor DNA Mutation Profiles in Metastatic breast cancer Patients with Multiline Resistance.
Hu ZY; Xie N; Tian C; Yang X; Liu L; Li J; Xiao H; Wu H; Lu J; Gao J; Hu X; Cao M; Shui Z; Xiao M; Tang Y; He Q; Chang L; Xia X; Yi X; Liao Q; Ouyang Q
EBioMedicine; 2018 Jun; 32():111-118. PubMed ID: 29807833
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-Penetrating Nanosystem Strongly Suppresses breast Tumor Growth.
Sharma S; Kotamraju VR; Mölder T; Tobi A; Teesalu T; Ruoslahti E
Nano Lett; 2017 Mar; 17(3):1356-1364. PubMed ID: 28178415
[TBL] [Abstract] [Full Text] [Related]
11. Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases.
Yun EJ; Song KS; Shin S; Kim S; Heo JY; Kweon GR; Wu T; Park JI; Lim K
Oncotarget; 2016 Aug; 7(31):49961-49971. PubMed ID: 27363023
[TBL] [Abstract] [Full Text] [Related]
12. An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.
Danjoux C; Chow E; Drossos A; Holden L; Hayter C; Tsao M; Barnes T; Sinclair E; Farhadian M
Support Care Cancer; 2006 Jan; 14(1):38-43. PubMed ID: 15856333
[TBL] [Abstract] [Full Text] [Related]
13. Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95--a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group Efficacy and Tolerability) trial.
Thürlimann B; Hess D; Köberle D; Senn I; Ballabeni P; Pagani O; Perey L; Aebi S; Rochlitz C; Goldhirsch A
Breast Cancer Res Treat; 2004 Jun; 85(3):247-54. PubMed ID: 15111763
[TBL] [Abstract] [Full Text] [Related]
14. Effects of adenoviral gene transfer of C. elegans n-3 fatty acid desaturase on the lipid profile and growth of human breast cancer cells.
Ge Y; Chen Z; Kang ZB; Cluette-Brown J; Laposata M; Kang JX
Anticancer Res; 2002; 22(2A):537-43. PubMed ID: 12014621
[TBL] [Abstract] [Full Text] [Related]
